Pathological Response of Locally Recurrent Rectal Cancer to Neoadjuvant Chemoradiotherapy
Open Access
- 25 January 2026
- journal article
- Published by The Japan Society of Coloproctology in Journal of the Anus, Rectum and Colon
- Vol. 10 (1) , 19-25
Abstract
Objectives: The primary objective was to elucidate the apoptotic response of locally recurrent rectal cancer (LRRC) to neoadjuvant chemoradiotherapy (CRT) using M30 CytoDeath immunostaining. Secondary objectives were to examine its association with tumor regression grade (TRG), tumor size reduction, and long-term outcomes.Methods: This retrospective study included nine patients who underwent CRT followed by radical surgery for LRRC between 2012 and 2020. TRG was evaluated according to the Japanese Classification of Colorectal Carcinoma. Apoptosis was assessed with M30 CytoDeath immunostaining, in which the proportion of stained cells was classified as score 0 (0-33%), score 1 (34-66%), score 2 (67-99%), and score 3 (100%). Tumor size reduction, R0 resection rate, and survival outcomes were also analyzed.Results: No patient achieved pathological complete response; most were TRG 1. By M30 CytoDeath staining, no case had a score ≥2, while score 0 was dominant. A few patients showed score 1, including those treated with oxaliplatin or irinotecan in addition to tegafur and uracil/leucovorin. Tumor size reduction was achieved in most patients, with an R0 resection rate of 77.8%. Among R0 cases, 5-year local re-recurrence-free and 3-year disease-free survival rates were 42.9% and 14.3%, respectively.Conclusions: Direct assessment of apoptosis demonstrated that LRRC is resistant to CRT-induced apoptosis. This resistance likely contributes to high local and distant recurrence after surgery, underscoring the need to develop more effective perioperative strategies for LRRC.Keywords
This publication has 25 references indexed in Scilit:
- Chemoradiotherapy response in recurrent rectal cancerCancer Medicine, 2013
- Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planesBritish Journal of Surgery, 2013
- Meta‐analysis of survival based on resection margin status following surgery for recurrent rectal cancerColorectal Disease, 2012
- Extended Radical Resection: The Choice for Locally Recurrent Rectal CancerDiseases of the Colon & Rectum, 2008
- Chemotherapy with Preoperative Radiotherapy in Rectal CancerNew England Journal of Medicine, 2006
- Preoperative Radiotherapy Improves Outcome in Recurrent Rectal CancerDiseases of the Colon & Rectum, 2005
- Total Pelvic Exenteration With Distal Sacrectomy for Fixed Recurrent Rectal Cancer in the PelvisDiseases of the Colon & Rectum, 2004
- Aggressive surgical management of recurrent rectal cancer—Is it worthwhile?Diseases of the Colon & Rectum, 1997
- Preoperative Infusional Chemoradiation, Selective Intraoperative Radiation, and Resection for Locally Advanced Pelvic Recurrence of Colorectal AdenocarcinomaAnnals of Surgery, 1996
- Pelvic Resection of Recurrent Rectal CancerAnnals of Surgery, 1994